“…The prognostic value of vimentin expression determined in tumor cells by immunohistochemistry before treatment was previously shown using univariate and multivariate analyses of overall and disease-free survival of patients with squamous cell CC and adenocarcinoma of the uterine cervix [ 40 , 41 , 42 , 43 ]. In addition, there have been growing data on the association of other EMT markers, including the transcription factors Snail, Slug, Twist, ZEB1, etc., and EMT-related molecules with poor prognosis of long-term clinical outcome [ 43 , 44 , 45 , 46 ]; at the same time, inhibitors or negative modulators of EMT were found to be factors of favorable prognosis of CC patients [ 47 , 48 ]. Taking into account these data, it made sense to analyze the informativeness of the vimentin expression assessment in non-invasive material of scrapings from the cervix before treatment to predict the clinical outcome.…”